Free Trial
OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

$1.90 0.00 (0.00%)
As of 08/8/2025

About EKIMAS Stock (OTCMKTS:ASNB)

Key Stats

Today's Range
$1.90
$1.90
50-Day Range
$1.90
$4.00
52-Week Range
$0.55
$1.75
Volume
25 shs
Average Volume
3,162 shs
Market Capitalization
$11.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

ASNB Stock News Headlines

EKIMAS CORPORATION COMPLETES THE EXERCISE OF WARRANTS
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Updated EKIMAS Corporation Announces Special Cash Distribution
What does ‘WYLL’ mean on TikTok and Snapchat?
EKIMAS Corporation (ASNB)
See More Headlines

ASNB Stock Analysis - Frequently Asked Questions

EKIMAS's stock was trading at $9.00 at the beginning of the year. Since then, ASNB stock has decreased by 78.9% and is now trading at $1.90.

EKIMAS Co. (OTCMKTS:ASNB) posted its quarterly earnings data on Thursday, October, 16th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.02.

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that EKIMAS investors own include Associated Banc (ASB), MediWound (MDWD), PermRock Royalty Trust (PRT), Meta Platforms (META), Adobe (ADBE), Actinium Pharmaceuticals (ATNM) and CytoDyn (CYDY).

Company Calendar

Last Earnings
10/16/2014
Today
8/11/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Business Services
Current Symbol
OTCMKTS:ASNB
Previous Symbol
AMEX:ASB
CIK
1011060
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-7,902.31%
Return on Assets
-5,274.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.12
Quick Ratio
0.12

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
63.33

Miscellaneous

Outstanding Shares
5,799,000
Free Float
5,347,000
Market Cap
$11.02 million
Optionable
Not Optionable
Beta
0.37
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:ASNB) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners